The objective of the present study was to investigate insulin-releasing and glucose-lowering actions of EEAA through in vitro and in vivo studies to explore its underlying mechanism of action for the treatment of Type 2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.